Home

Articles from Tenvie Therapeutics, Inc.

Tenvie Therapeutics Promotes Tony Estrada, PhD, to Chief Executive Officer
Proven drug development leader to drive company’s pipeline of highly CNS-penetrant and precision-designed peripherally restricted small molecules toward clinical milestones
By Tenvie Therapeutics, Inc. · Via GlobeNewswire · July 23, 2025
Tenvie Therapeutics Launches with $200 Million to Deliver Breakthrough Small Molecule Therapies
Advancing a deep pipeline of therapeutics focused on treating neurological, cardiometabolic, and ophthalmic diseases
By Tenvie Therapeutics, Inc. · Via GlobeNewswire · January 8, 2025